No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
65 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
32 (estimated)
Sponsor
Wake Forest University Health Sciences · Other
Who this trial is looking for
This trial is looking for adults aged 65 and older who are starting chemotherapy for cancer. Participants will help researchers understand how to provide better care based on their individual needs and resilience.
Are You a Good Fit for This Trial?
You may be able to join if
I am at least 65 years old.
I am starting outpatient chemotherapy for cancer.
I am willing to sign an informed consent form.
I can read and understand English.
I have an eFI pre-frail or frail status.
You may not be able to join if
I have a physical or psychological condition that affects my ability to take part.
I am currently receiving chemotherapy.
I am getting chemotherapy outside of the Atrium Health system.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
The study purpose is to gain a better understanding of the needs of adults aged 65 and older while they are receiving chemotherapy by measuring their resilience and tailor care plans based on their individual needs.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
Patients with cancer:
* Ability to understand and willingness to sign an IRB-approved informed consent
* Age ≥ 65 years at the time of enrollment.
* Planned to initiate an outpatient chemotherapy regimen (including myelosuppressive biologic/immune therapies) for cancer treatmen…
Inclusion Criteria:
Patients with cancer:
* Ability to understand and willingness to sign an IRB-approved informed consent
* Age ≥ 65 years at the time of enrollment.
* Planned to initiate an outpatient chemotherapy regimen (including myelosuppressive biologic/immune therapies) for cancer treatment (any type or stage), either as an initial therapy or as a new line of therapy, with curative or palliative intent.
* eFI pre-frail or frail status (available in EHR; defined as eFI \> 0.10) within 30 days before enrollment.
* Ability to read and understand the English language
Providers:
* Treating medical oncologist of at least one patient participant who enrolled on to the study and completed baseline assessment.
Exclusion Criteria:
Patients:
* Documented physical or psychological comorbidity that would limit participant's ability to understand or comply with study procedures for the entire length of the study per the enrolling investigator.
* Chemotherapy planned at a facility outside the Atrium Health system.
* Currently receiving chemotherapy (defined as planned to continue an on-going treatment rather than starting a new regimen).
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
